Drug intelligence / Profile preview

NI-hMSCs

Development stage: Preclinical
Lead developer: Cell Reprogramming & Therapeutics
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intranasal, Intrathecal, Intravenous, Intra-arterial, Inhalation, Intraperitoneal

Overview

NI-hMSCs (Neurally Induced Human Mesenchymal Stem Cells) is a cell therapy candidate developed by Cell Reprogramming & Therapeutics for the treatment of various neurodegenerative diseases and central nervous system (CNS) injuries. The therapy is generated using a proprietary chemical genetics-based cell reprogramming platform that employs small molecules to convert human mesenchymal stem cells (hMSCs) or human adult fat cells into neural-like cells. These reprogrammed cells are intended to provide neuroregenerative and neuroprotective effects in conditions such as Parkinson's disease, Alzheimer's disease, Huntington's disease, Amyotrophic Lateral Sclerosis (ALS), stroke, and other CNS injuries. The program is currently in the preclinical stage of development.

Other names: Neurally Induced Human Mesenchymal Stem Cellsneural-like hMSCs

Beyond the preview

Go deeper on NI-hMSCs.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NI-hMSCs.

Explore the full profile